Abstract: Various embodiments of the invention provide novel software, systems and methods for animation and/or filmmaking. In a set of embodiments, for example, a client-server system provides the ability to control various aspects of a live-action and/or an animated scene, including cameras and/or light sources (either real and/or virtual), animated characters, and other objects. This can include, merely by way of example, moving cameras, light and/or the like, as well as rendering animated objects (e.g., based on movements of the objects themselves and/or based on movements of cameras, lights, etc.).

Abstract: Embodiments of the invention provide novel controllers for filmmaking and/or animation, as well as systems and methods for their use. In a set of embodiments, a controller has an actuator (e.g., a joystick, etc.) that receives input from a user for controlling an object, such as a camera, a light, an animated character, etc. The input is provided as instructions, which are described according to a reference coordinate system, to a movement system for moving the object within a scene (i.e., relative to other objects within the scene). The controller may include an additional control allowing the user to define an auxiliary coordinate system, such that the input from the user is described according to the auxiliary coordinate system. Alternatively and/or additionally, the controller includes a control for allowing the user to select whether input should be described according to the auxiliary coordinate system or the reference coordinate system.

Abstract: Compounds of general formula (1) are described wherein: Ar is an optionally substituted aromatic group; R2 is a hydrogen or halogen atom or a group —X1—R2a where X1 is a direct bond or a linker atom or group, and R2a is an optionally substituted straight or branched chain alkyl, alkenyl or alkynyl group; R3 is an optionally substituted heterocycloalkyl group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are selective protein tyrosine kinase inhibitors, particularly the kinases ZAP-70 and syk and are of use in the prophylaxis and treatment of immune or allergic diseases and diseases involving inappropriate platelet activation.

Abstract: Compounds of general formula (1) ##STR1## are described wherein: Ar is an optionally substituted aromatic group;R.sup.2 is a hydrogen or halogen atom or a group --X.sup.1 --R.sup.2a where X.sup.1 is a direct bond or a linker atom or group, and R.sup.2a is an optionally substituted straight or branched chain alkyl, alkenyl or alkynyl group;R.sup.3 is an optionally substituted heterocycloalkyl group; and the salts, solvates, hydrates and N-oxides thereof.The compounds are selective protein tyrosine kinase inhibitors, particularly the kinases ZAP-70 and syk and are of use in the prophylaxis and treatment of immune or allergic diseases and diseases involving inappropriate platelet activation.